Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Actins | 9 | 2010 | 99 | 1.090 |
Why?
|
| Antineoplastic Agents, Phytogenic | 3 | 2016 | 54 | 0.390 |
Why?
|
| Gingiva | 1 | 2012 | 8 | 0.380 |
Why?
|
| Periodontitis | 1 | 2012 | 11 | 0.380 |
Why?
|
| Cytoskeleton | 5 | 2001 | 45 | 0.370 |
Why?
|
| Diabetes Complications | 1 | 2012 | 66 | 0.370 |
Why?
|
| Receptors, Immunologic | 1 | 2012 | 73 | 0.370 |
Why?
|
| Neomycin | 4 | 2001 | 7 | 0.330 |
Why?
|
| Microscopy, Fluorescence | 7 | 2010 | 163 | 0.330 |
Why?
|
| Fibroblasts | 4 | 2001 | 160 | 0.330 |
Why?
|
| Tubulin | 3 | 1998 | 32 | 0.280 |
Why?
|
| Actin Cytoskeleton | 2 | 2007 | 24 | 0.260 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2007 | 4 | 0.260 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2007 | 19 | 0.260 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2007 | 18 | 0.260 |
Why?
|
| Paclitaxel | 2 | 2006 | 200 | 0.250 |
Why?
|
| Microscopy, Electron, Scanning | 4 | 2010 | 73 | 0.210 |
Why?
|
| Microscopy, Confocal | 3 | 2010 | 113 | 0.180 |
Why?
|
| Pseudopodia | 1 | 2001 | 7 | 0.180 |
Why?
|
| Staining and Labeling | 2 | 2012 | 69 | 0.170 |
Why?
|
| Gelsolin | 2 | 2001 | 7 | 0.170 |
Why?
|
| Cytoskeletal Proteins | 2 | 1998 | 42 | 0.160 |
Why?
|
| Flow Cytometry | 3 | 2007 | 292 | 0.130 |
Why?
|
| HL-60 Cells | 2 | 2007 | 22 | 0.130 |
Why?
|
| Phalloidine | 1 | 1996 | 1 | 0.130 |
Why?
|
| Cross-Linking Reagents | 1 | 1996 | 43 | 0.120 |
Why?
|
| Isothiocyanates | 1 | 2016 | 11 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 29 | 0.120 |
Why?
|
| Phosphatidylinositols | 2 | 1995 | 25 | 0.120 |
Why?
|
| Cyclin D1 | 1 | 2016 | 38 | 0.120 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 105 | 0.110 |
Why?
|
| Humans | 14 | 2016 | 28851 | 0.110 |
Why?
|
| Apoptosis | 3 | 2016 | 780 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 1998 | 536 | 0.100 |
Why?
|
| Inovirus | 2 | 2010 | 4 | 0.100 |
Why?
|
| Cell Movement | 3 | 2001 | 376 | 0.100 |
Why?
|
| Microscopy, Video | 3 | 2010 | 18 | 0.100 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2012 | 12 | 0.100 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 82 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 360 | 0.090 |
Why?
|
| Cell Cycle | 2 | 2016 | 163 | 0.090 |
Why?
|
| Biopsy | 1 | 2012 | 208 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2012 | 391 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 465 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2016 | 1350 | 0.090 |
Why?
|
| Oncolytic Virotherapy | 1 | 2010 | 12 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 465 | 0.080 |
Why?
|
| Virus Attachment | 1 | 2010 | 3 | 0.080 |
Why?
|
| Toxicity Tests | 1 | 2010 | 11 | 0.080 |
Why?
|
| Alginates | 1 | 2010 | 14 | 0.080 |
Why?
|
| Cell Line | 4 | 2010 | 700 | 0.080 |
Why?
|
| Hydrogels | 1 | 2010 | 59 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2010 | 265 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2001 | 1022 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2006 | 114 | 0.060 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 82 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 1996 | 314 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2006 | 138 | 0.060 |
Why?
|
| Chromatin | 1 | 2006 | 76 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 482 | 0.060 |
Why?
|
| Time Factors | 2 | 2001 | 1613 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 612 | 0.050 |
Why?
|
| Vimentin | 2 | 2002 | 28 | 0.050 |
Why?
|
| Caspases | 1 | 2002 | 43 | 0.050 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2001 | 13 | 0.040 |
Why?
|
| Cell Survival | 2 | 2016 | 419 | 0.040 |
Why?
|
| Cell Division | 1 | 2001 | 154 | 0.040 |
Why?
|
| Culture Media, Serum-Free | 2 | 1998 | 12 | 0.040 |
Why?
|
| Middle Aged | 1 | 2012 | 7414 | 0.040 |
Why?
|
| Adult | 1 | 2012 | 8024 | 0.040 |
Why?
|
| Protein Binding | 1 | 2001 | 667 | 0.040 |
Why?
|
| Bacterial Toxins | 1 | 2002 | 273 | 0.040 |
Why?
|
| Gout Suppressants | 1 | 1998 | 1 | 0.040 |
Why?
|
| Colchicine | 1 | 1998 | 16 | 0.040 |
Why?
|
| Female | 2 | 2012 | 15624 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2002 | 497 | 0.030 |
Why?
|
| Male | 2 | 2012 | 13921 | 0.030 |
Why?
|
| Skin | 1 | 1998 | 152 | 0.030 |
Why?
|
| Buffers | 1 | 1996 | 25 | 0.030 |
Why?
|
| Animals | 5 | 2002 | 10684 | 0.030 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1996 | 50 | 0.030 |
Why?
|
| Sulfoxides | 1 | 2016 | 6 | 0.030 |
Why?
|
| Tissue Fixation | 1 | 1995 | 7 | 0.030 |
Why?
|
| Freeze Drying | 1 | 1995 | 10 | 0.030 |
Why?
|
| Vertebrates | 1 | 1995 | 18 | 0.030 |
Why?
|
| Dogs | 1 | 1996 | 510 | 0.030 |
Why?
|
| Kinetics | 1 | 1995 | 553 | 0.030 |
Why?
|
| Glioma | 1 | 1995 | 122 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 472 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1993 | 26 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 824 | 0.020 |
Why?
|
| Oncogene Proteins | 1 | 1991 | 23 | 0.020 |
Why?
|
| Oncogenes | 1 | 1991 | 34 | 0.020 |
Why?
|
| Directed Molecular Evolution | 1 | 2010 | 7 | 0.020 |
Why?
|
| Peptide Library | 1 | 2010 | 26 | 0.020 |
Why?
|
| Coumarins | 1 | 2010 | 5 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2010 | 31 | 0.020 |
Why?
|
| Ligands | 1 | 2010 | 178 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1991 | 120 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2010 | 97 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2010 | 35 | 0.020 |
Why?
|
| Prodrugs | 1 | 2010 | 30 | 0.020 |
Why?
|
| Glutathione | 1 | 2010 | 76 | 0.020 |
Why?
|
| Drug Carriers | 1 | 2010 | 119 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 117 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 697 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 236 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 686 | 0.010 |
Why?
|
| Caspase Inhibitors | 1 | 2002 | 8 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2002 | 58 | 0.010 |
Why?
|
| CHO Cells | 1 | 2002 | 96 | 0.010 |
Why?
|
| Cricetinae | 1 | 2002 | 131 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2002 | 267 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2002 | 212 | 0.010 |
Why?
|
| Transfection | 1 | 2002 | 319 | 0.010 |
Why?
|
| Cytochalasin D | 1 | 1993 | 10 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1993 | 46 | 0.010 |
Why?
|
| Neuroglia | 1 | 1993 | 30 | 0.010 |
Why?
|
| Penis | 1 | 1993 | 17 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1993 | 106 | 0.010 |
Why?
|
| Mice | 2 | 1993 | 4802 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1991 | 94 | 0.010 |
Why?
|
| Lung | 1 | 1993 | 382 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1993 | 916 | 0.000 |
Why?
|
| Signal Transduction | 1 | 1993 | 1469 | 0.000 |
Why?
|
Safiejko-Mroczka's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(125)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(3)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_